Life Summary
John Rim is the CEO and President of Samsung Biologics. He also serves as the Chairman of the Board of Directors.

Born in October 1961 in South Korea, he later immigrated to the United States and holds U.S. citizenship.

He graduated from Columbia University with a degree in chemical engineering. He earned a master's degree in chemical engineering from Stanford University and completed an MBA program at Northwestern University’s Kellogg School of Management.

After working at the consulting firm Booz & Company, he served as Chief Financial Officer (CFO) of the U.S. subsidiary of the Japanese pharmaceutical company Yamanouchi.

He also worked as the CFO of the American biotech company Genentech and the CFO of the U.S. subsidiary of the multinational pharmaceutical company Roche.

He joined Samsung Biologics, serving as Vice President in charge of Plant 3 and later as Head of Process Operations. In 2021, he was appointed as CEO and President.

He is focused on expanding the production capacity of biopharmaceuticals to position the company as the world's leading Contract Development and Manufacturing Organization (CDMO).

#JohnRim #SamsungBiologics #biotechnology #chemicalengineering #CDMO #globalbusiness #pharmaceuticals #businessleadership #CEOprofile #biopharma